Sharemaestro Newsreel

First Trust Advisors LP Has $2.85 Million Stake in Omnicell, Inc. $OMCL

First Trust Advisors LP significantly reduced its stake in Omnicell, Inc. during the first quarter, selling over 46,000 shares but still retaining a $2.85 million position. Despite this reduction, institutional investors collectively own a substantial 97.7% of OMCL. Analyst sentiment remains largely positive, with …

SpaceX, Doximity, Trade Desk, Rigetti, Coherent, and More Stocks That Explain Today’s Market

FEATURE Stocks rose Friday with tech names picking up steam after the U.S. jobs report for July was softer than expected, resulting in Wall Street rethinking whether the Federal Reserve will raise interest rates any time soon. Continue Reading

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics TXG reported a second-quarter 2026 loss of 14 cents per share against earnings of 28 cents in the year-ago quarter, representing a 150% year-over-year decline. Still, the figure beat the Zacks Consensus Estimate of a loss of 23 cents by 38.1%. Revenues …

Can Weight-Loss Momentum Lift Hims & Hers Stock Before Q2 Earnings?

Hims & Hers Health, Inc. HIMS is scheduled to report second-quarter 2026 results on Aug. 10, after the closing bell. In the last reported quarter, the company's loss per share of 18 cents lagged the Zacks Consensus Estimate of earnings per share of 4 …

DarioHealth Corp expected to post a loss of $1.21 a share - Earnings Preview

DarioHealth Corp is anticipated to report an upcoming earnings loss. Analysts predict the company will post a loss of $1.21 per share. This information is based on an earnings preview from Refinitiv.

Claritev Stock (CTEV) Opinions on Q2 Earnings Beat

HealthStream Inc Q2 2026: Revenue $83.73M, EPS $0.23— 10-Q Summary

HealthStream Inc (HSTM) reported strong Q2 2026 results with revenue reaching $83.73M, a 12.5% increase year-over-year, and diluted EPS of $0.23, up from $0.18 in Q2 2025. Net income also saw a significant rise to $6.67M. The growth was primarily driven by subscription services, …

Certara (CERT) Could Be 9% Undervalued On Earnings Guidance And Buyback News

Why Health Catalyst (HCAT) Shares Are Trading Lower Today

Health Catalyst (HCAT) shares fell 23.1% after the company issued a weak third-quarter revenue forecast and lowered its full-year outlook, despite exceeding second-quarter revenue expectations. The reduced guidance overshadowed the company's Q2 performance and indicates significant challenges ahead. This significant drop follows a recent …

Omada Health Inc. (OMDA) Stock Price | Live Quotes & Charts | NASDAQ

This page provides live quotes and charts for Omada Health Inc. (OMDA), showing its current stock price and recent performance. It notes a significant price increase for OMDA and indicates that analyst ratings and earnings information are not currently available. The page also includes …

CCLD: With its Series B Preferred Redeemed and Merger Integration Costs Mostly Over, CareCloud Looks to EPS Growth Going Forward

CareCloud (CCLD) has redeemed its Series B Preferred shares, replacing them with lower-cost debt, which is expected to benefit common shareholders and simplify its balance sheet. The company also expanded its offerings by acquiring Empower Healthcare and Compliance Partners, and is seeing success with …

Claritev earnings beat by $0.67, revenue topped estimates

Vsee Health Inc (VSEE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Veeva Systems (VEEV) Heads Into Earnings With An Undervalued Narrative In Focus

Health Catalyst Shares Tumble Overnight: What Investors Need to Know

Health Catalyst (HCAT) shares plummeted 24.68% in overnight trading after the company issued lower-than-expected third-quarter revenue guidance, despite exceeding its second-quarter revenue guidance. The healthcare intelligence company reported a 13% year-over-year revenue decline in Q2 but saw adjusted EBITDA increase. Investors reacted negatively to …

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

Health Catalyst (HCAT) reported Q2 2026 revenue of $70.49 million, exceeding the Zacks Consensus Estimate by 2.33%, despite a 12.7% year-over-year decline. The company's EPS of $0.04 surpassed the consensus estimate of $0.02 by 100%. Key metrics like professional services revenue and adjusted gross …

Omada Health promotes President Wei-Li Shao to CEO

Omada Health has promoted its President, Wei-Li Shao, to the position of Chief Executive Officer. The announcement was made by Joyce Famakinwa on August 7, 2026. This move signifies a leadership transition within the health tech company.

CTEV | Claritev Corporation Financials - Income Statement

Schrodinger Inc (SDGR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Earnings call transcript: Claritev posts Q2 2026 beat, but shares fall premarket

Weave Communications Inc (WEAV) Stock News Today

Claritev (NYSE:CTEV) Trading 41.9% Higher After Strong Earnings

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky has announced a securities investigation into Teladoc Health (TDOC) after its shares dropped over 28%. This plunge followed Teladoc's report of Q2 2026 revenue below consensus and a cut in its full-year 2026 revenue guidance. The investigation focuses on potential materially …

Spok Holdings, Inc. (SPOK) Stock Price, News, Quote & History

This article provides detailed financial information for Spok Holdings, Inc. (SPOK), including its current stock price, dividend announcements, historical performance, and company overview. It also includes financial metrics, analyst insights, and comparisons with similar companies in the healthcare information services industry.

LifeMD (NASDAQ:LFMD) Price Target Lowered to $9.00 at HC Wainwright

HC Wainwright has lowered its price target for LifeMD (NASDAQ:LFMD) to $9.00 from $10.00 but maintained a "buy" rating, indicating a potential upside of 164.71%. The revision follows LifeMD's recent quarterly results, which missed analyst expectations with a reported loss of $0.16 per share …

Carlsmed (CARL) Stock Revenue Surge Meets A Wider Loss Per Share

Carlsmed (CARL) reported a Q2 2026 revenue increase of 57% year-on-year to US$18.94m, yet experienced a widening net loss of US$10.51m and a widened basic loss per share of US$0.39. Despite strong revenue growth and improved gross margins, the company faces challenges with ongoing …

OptimizeRx Corp (OPRX) Stock News Today

This article provides current stock information for OptimizeRx Corp (OPRX), including its latest stock price, market capitalization, and P/E ratio. It indicates that more news and analysis for OPRX will be published soon.

Earnings To Watch: Definitive Healthcare Corp (DH) Q2 2026 -- GF Value Sees 520% Upside

Doximity Jumps On Earnings: Explaining The Outsized Stock Move (Rating Upgrade) (DOCS)

Doximity Shares Soar After Revenue Beat and Higher Full-Year Forecast

Certara, Inc. $CERT Shares Sold by Sei Investments Co.

Sei Investments Co. significantly reduced its stake in Certara, Inc. (NASDAQ:CERT) by 43.6% in the first quarter, selling 479,880 shares but retaining 620,967 shares valued at approximately $3.54 million. Despite other institutional investors increasing their holdings, Certara reported a quarterly EPS of $0.08, missing …

American Well Corporation (NYSE:AMWL) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.90

American Well Corporation (NYSE:AMWL) recently released strong quarterly results, with revenues exceeding analyst forecasts and statutory losses being smaller than expected. Analysts have maintained their revenue estimates for 2026 but significantly reduced their loss per share forecasts, leading to a 34% increase in the …

CareCloud, Inc. (CCLD) stock price, news, quote and history

This Yahoo Finance page provides a comprehensive overview of CareCloud, Inc. (CCLD) stock, including its current price, market performance, and historical data. It details the company's profile as a healthcare information technology provider, offering various software and services to healthcare entities. The page also …

Weave Communications (NYSE: WEAV) grows Q2 2026 revenue 15.5% and turns non-GAAP profit

Weave Communications (NYSE: WEAV) announced strong Q2 2026 results, with revenue increasing by 15.5% year-over-year to $67.5 million and achieving a non-GAAP net income of $3.3 million. The company also reported significant improvements in operating cash flow and free cash flow, doubling from the …

Claritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue Estimates

Claritev Updates 2026 Revenue Guidance to $1B-$1.02B After Q2